Logo image of GRVY

GRAVITY CO LTD-SPONSORED ADR (GRVY) Stock Fundamental Analysis

USA - NASDAQ:GRVY - US38911N2062 - ADR

60.85 USD
-0.45 (-0.73%)
Last: 10/7/2025, 10:33:49 AM
Fundamental Rating

6

GRVY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 80 industry peers in the Entertainment industry. GRVY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. GRVY has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year GRVY was profitable.
Each year in the past 5 years GRVY has been profitable.
Each year in the past 5 years GRVY had a positive operating cash flow.
GRVY Yearly Net Income VS EBIT VS OCF VS FCFGRVY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

1.2 Ratios

GRVY has a Return On Assets of 11.18%. This is amongst the best in the industry. GRVY outperforms 88.75% of its industry peers.
GRVY has a Return On Equity of 13.56%. This is amongst the best in the industry. GRVY outperforms 82.50% of its industry peers.
GRVY's Return On Invested Capital of 11.50% is amongst the best of the industry. GRVY outperforms 87.50% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GRVY is significantly above the industry average of 9.15%.
The last Return On Invested Capital (11.50%) for GRVY is well below the 3 year average (21.19%), which needs to be investigated, but indicates that GRVY had better years and this may not be a problem.
Industry RankSector Rank
ROA 11.18%
ROE 13.56%
ROIC 11.5%
ROA(3y)17.98%
ROA(5y)19.54%
ROE(3y)22.9%
ROE(5y)26.19%
ROIC(3y)21.19%
ROIC(5y)26.48%
GRVY Yearly ROA, ROE, ROICGRVY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

Looking at the Profit Margin, with a value of 14.26%, GRVY belongs to the top of the industry, outperforming 91.25% of the companies in the same industry.
In the last couple of years the Profit Margin of GRVY has grown nicely.
Looking at the Operating Margin, with a value of 15.53%, GRVY belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
GRVY's Operating Margin has improved in the last couple of years.
GRVY has a Gross Margin (36.65%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GRVY has grown nicely.
Industry RankSector Rank
OM 15.53%
PM (TTM) 14.26%
GM 36.65%
OM growth 3Y-9.86%
OM growth 5Y4.98%
PM growth 3Y2.1%
PM growth 5Y8.95%
GM growth 3Y-5.47%
GM growth 5Y7.99%
GRVY Yearly Profit, Operating, Gross MarginsGRVY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

9

2. Health

2.1 Basic Checks

GRVY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The debt/assets ratio for GRVY has been reduced compared to a year ago.
GRVY Yearly Shares OutstandingGRVY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M
GRVY Yearly Total Debt VS Total AssetsGRVY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

GRVY has an Altman-Z score of 6.04. This indicates that GRVY is financially healthy and has little risk of bankruptcy at the moment.
GRVY's Altman-Z score of 6.04 is amongst the best of the industry. GRVY outperforms 81.25% of its industry peers.
There is no outstanding debt for GRVY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.04
ROIC/WACC5.09
WACC2.26%
GRVY Yearly LT Debt VS Equity VS FCFGRVY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B 400B 500B

2.3 Liquidity

GRVY has a Current Ratio of 5.82. This indicates that GRVY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.82, GRVY belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
GRVY has a Quick Ratio of 5.82. This indicates that GRVY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.82, GRVY belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.82
Quick Ratio 5.82
GRVY Yearly Current Assets VS Current LiabilitesGRVY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2

3. Growth

3.1 Past

The earnings per share for GRVY have decreased strongly by -10.23% in the last year.
Measured over the past years, GRVY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.49% on average per year.
GRVY shows a small growth in Revenue. In the last year, the Revenue has grown by 0.33%.
The Revenue has been growing slightly by 6.77% on average over the past years.
EPS 1Y (TTM)-10.23%
EPS 3Y9.05%
EPS 5Y16.49%
EPS Q2Q%5.38%
Revenue 1Y (TTM)0.33%
Revenue growth 3Y6.56%
Revenue growth 5Y6.77%
Sales Q2Q%38.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRVY Yearly Revenue VS EstimatesGRVY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

4

4. Valuation

4.1 Price/Earnings Ratio

GRVY is valuated cheaply with a Price/Earnings ratio of 7.39.
Compared to the rest of the industry, the Price/Earnings ratio of GRVY indicates a rather cheap valuation: GRVY is cheaper than 91.25% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of GRVY to the average of the S&P500 Index (27.90), we can say GRVY is valued rather cheaply.
Industry RankSector Rank
PE 7.39
Fwd PE N/A
GRVY Price Earnings VS Forward Price EarningsGRVY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GRVY is valued cheaper than 86.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.4
GRVY Per share dataGRVY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

GRVY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.45
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GRVY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GRAVITY CO LTD-SPONSORED ADR

NASDAQ:GRVY (10/7/2025, 10:33:49 AM)

60.85

-0.45 (-0.73%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-10 2025-11-10
Inst Owners16.86%
Inst Owner Change0.02%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap422.84M
Analysts0
Price TargetN/A
Short Float %0.18%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.39
Fwd PE N/A
P/S 1.05
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1.02
EV/EBITDA 6.4
EPS(TTM)8.23
EY13.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS57.71
BVpS60.71
TBVpS59.8
PEG (NY)N/A
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 13.56%
ROCE 14.55%
ROIC 11.5%
ROICexc 11.5%
ROICexgc 11.67%
OM 15.53%
PM (TTM) 14.26%
GM 36.65%
FCFM N/A
ROA(3y)17.98%
ROA(5y)19.54%
ROE(3y)22.9%
ROE(5y)26.19%
ROIC(3y)21.19%
ROIC(5y)26.48%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.81%
ROCE(5y)33.51%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-70.66%
OM growth 3Y-9.86%
OM growth 5Y4.98%
PM growth 3Y2.1%
PM growth 5Y8.95%
GM growth 3Y-5.47%
GM growth 5Y7.99%
F-ScoreN/A
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.82
Quick Ratio 5.82
Altman-Z 6.04
F-ScoreN/A
WACC2.26%
ROIC/WACC5.09
Cap/Depr(3y)76.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.86%
Profit Quality(3y)99.21%
Profit Quality(5y)101.85%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.23%
EPS 3Y9.05%
EPS 5Y16.49%
EPS Q2Q%5.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.33%
Revenue growth 3Y6.56%
Revenue growth 5Y6.77%
Sales Q2Q%38.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.21%
EBIT growth 3Y-3.95%
EBIT growth 5Y12.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.73%
FCF growth 3Y1.79%
FCF growth 5Y25.16%
OCF growth 1Y-40.68%
OCF growth 3Y1.93%
OCF growth 5Y24.4%